Menu
Back to User profile » Dr Michael D Stensland
Papers published by Dr Michael D Stensland:
Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial
Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VSL, Stensland MD, Hanania NA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:499-508
Published Date: 5 February 2018
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
Ganapathy V, Stensland MD
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1793-1801
Published Date: 20 June 2017
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
Ye W, Montgomery W, Kadziola Z, Liu L, Xue H, Stensland MD, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:869-878
Published Date: 16 May 2014
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H
ClinicoEconomics and Outcomes Research 2013, 5:407-418
Published Date: 14 August 2013